Riociguat is a stimulator of soluble guanylyl cyclase (sGC), used as an active pharmaceutical ingredient in the manufacturing of medications for pulmonary hypertension. It is the first drug in its class and is primarily indicated for chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Riociguat?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Pholcodine monohydrate
pharmaceutical raw material
(+)-Cloprostenol sodium
pharmaceutical raw material
Emideltide
pharmaceutical raw material
Captopril
pharmaceutical raw material
Vericiguat
pharmaceutical raw material
2-(5-Fluoro-1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl)pyrimidine-4,5,6-triamine
pharmaceutical intermediate
The international HS code for Riociguat (CAS 625115-55-1) is 2933.59.
2933.59
2933 59 95
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
methyl N-[4,6-diamino-2-[1-[(2-fluorophenyl)methyl]pyrazolo[5,4-b]pyridin-3-yl]pyrimidin-5-yl]-N-methylcarbamate
WXXSNCNJFUAIDG-UHFFFAOYSA-N
CN(C1=C(N=C(N=C1N)C2=NN(C3=C2C=CC=N3)CC4=CC=CC=C4F)N)C(=O)OC
Sourcing Riociguat?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.